RPL39 and central nervous system cancer: Next, the TCGA database was used to explore the effect of RPL39 on the survival of glioma patients, and the KM curve showed that the survival time of glioma patients with high RPL39 expression was significantly shorter than that of glioma patients with low RPL39 expression (Figure 10F).